South Korea Blood Bags Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Single Blood Bags, Double Blood Bags, Triple Blood Bags, Quadruple Blood Bags, and Others), By Material (PVC, PET, and Others), and South Korea Blood Bags Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Sep 2025
REPORT ID SI15517
PAGES 210
REPORT FORMAT PathSoft

South Korea Blood Bags Market Insights Forecasts to 2035

  • The South Korea Blood Bags Market Size was Estimated at USD 6.9 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 8.13% from 2025 to 2035
  • The South Korea Blood Bags Market Size is Expected to Reach USD 16.3 Million by 2035

South Korea Blood Bags Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, The South Korea Blood Bags Market Size is anticipated to reach USD 16.3 Million by 2035, growing at a CAGR of 8.13% from 2025 to 2035. The market is driven by rising demand for blood transfusions in surgeries, trauma care, and oncology treatments. In addition, national blood donation programs and innovations in multi-bag systems with better safety and storage solutions boost adoption.

 

Market Overview

The South Korea Blood Bags Market comprises the medical devices proportion in the collection, storage, separation, and transfusion of whole blood and its components (red blood cells, plasma, and platelets). The market is growing steadily due to a growing demand for blood bags from hospitals, blood banks, and emergency care centers due to increased number of surgeries, trauma cases and other chronic diseases. Blood bags are also used in treating cancer and anemia. Also, blood bag technology has improved with the advent of triple and quadruplet bags for separating blood components, DEHP free materials, and integrated leukoreduction filters for safety and efficiency. In the face of national drives to increase blood donation, many of the policies associated with blood donation favors the blood bags market. In spite of pricing pressure and regulatory challenges, the market reveals a strong future for improvement through advancement in technology and distribution networks.

 

Report Coverage

This research report categorizes the market for the South Korea blood bags market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea blood bags market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea blood bags market.

 

South Korea Blood Bags Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 6.9 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :8.13%
2035 Value Projection:USD 16.3 Million
Historical Data for:2020-2023
No. of Pages:210
Tables, Charts & Figures:123
Segments covered:By Product Type, By Material
Companies covered:: Terumo Corporation, Fresenius Kabi AG, Grifols, S.A., Macopharma SA, Haemonetics Corporation, JMS Co., Ltd., B. Braun Melsungen AG, Nipro Corporation, Others
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis.

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The South Korea blood bags market is driven by a increasing need blood transfusions in surgery, trauma care, oncology and obstetrics. Additionally, development and implementation of blood donation programs led by the government, refinement in multi-bag systems for separating components of blood, advances in DEHP-free materials, and improving leucoreduction technology unlock opportunities for both safety and efficiency. And many new hospital establishments and improved means of procurement, are also favorable for the growth of the blood bags market.

 

Restraining Factors

The South Korea blood bags market is restrained by cost pressure in hospital and blood bank tenders and in low priced imports. Competition from imports is a restraint on revenue levels. The market is constrained by plasticizer regulatory pressure, medical waste management issues, and inventory risk due to the short shelf life of blood bags.

 

Market Segmentation

The South Korea Blood Bags Market share is classified into product type and material.

 

  • The triple blood bags segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea blood bags market is segmented by product type into single blood bags, double blood bags, triple blood bags, quadruple blood bags, and others. Among these, the triple blood bags segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Triple blood bags allow for simple separation of red cells, plasma, and platelets, making them popular at advanced health facilities. They also help optimize inventory management and address the information explosion of component therapy during surgery and in oncology. Their functionality is ubiquitous.

 

  • The PVC segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea blood bags market is segmented by material into PVC, PET, and others. Among these, the PVC segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. PVC is the leading material in the blood bag market due to its flexibility, durability, and affordability. It is used extensively for sterile medical-grade bag making and has compatibility with the anticoagulant-preservative solutions as well. Though there is some regulatory scrutiny over use with DEHP plasticizers, PVC continues to maintain leadership in terms of usage in South Korea.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea blood bags market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Terumo Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Macopharma SA
  • Haemonetics Corporation
  • JMS Co., Ltd.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea blood bags market based on the below-mentioned segments:

 

South Korea Blood Bags Market, By Product Type

  • Single Blood Bags
  • Double Blood Bags
  • Triple Blood Bags
  • Quadruple Blood Bags
  • Others

 

South Korea Blood Bags Market, By Material

  • PVC
  • PET
  • Others

Frequently Asked Questions (FAQ)

  • 1. What is the market size of the South Korea Blood Bags Market in 2024 and its expected growth by 2035?
    The South Korea Blood Bags Market was valued at USD 6.9 million in 2024 and is expected to reach USD 16.3 million by 2035, growing at a CAGR of 8.13% during the forecast period 2025–2035.
  • 2. What are the key drivers of the South Korea Blood Bags Market?
    Key drivers include rising demand for blood transfusions in surgeries, trauma care, oncology, and obstetrics, national blood donation programs, and advancements in multi-bag systems, DEHP-free materials, and leukoreduction technology that enhance safety and efficiency.
  • 3. What factors are restraining the growth of the South Korea Blood Bags Market?
    The market faces restraints such as cost pressures in hospital and blood bank tenders, competition from low-priced imports, regulatory scrutiny over plasticizers, challenges in medical waste management, and inventory risks due to the short shelf life of blood bags.
  • 4. Which product type segment dominated the South Korea Blood Bags Market in 2024?
    The triple blood bags segment held the largest share in 2024, owing to their ability to efficiently separate red cells, plasma, and platelets, making them highly preferred in advanced healthcare facilities and hospitals with high transfusion demands.
  • 5. Which material segment accounted for the largest market share in 2024?
    The PVC segment dominated the South Korea blood bags market in 2024, due to its durability, flexibility, affordability, and compatibility with anticoagulant-preservative solutions, despite regulatory scrutiny on DEHP plasticizers.
  • 6. Who are the major companies operating in the South Korea Blood Bags Market?
    Key companies active in the market include Terumo Corporation, Fresenius Kabi AG, Grifols S.A., Macopharma SA, Haemonetics Corporation, JMS Co., Ltd., B. Braun Melsungen AG, and Nipro Corporation.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies